Influence of HLA-DRB1 alleles and HBV genotypes on interferon-&alpha; therapy for chronic hepatitis B

doi:10.3748/wjg.v11.i30.4753

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2682)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

259

HTML

2019

Figures (1-2)

215

Tables (1-5)

189

Sum=2682

Aug 14, 2005 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Aug 14, 2005; 11(30): 4753-4757
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4753

Full Size Figure Download Figure

Figure 2 Electrophoresis of HBV genotypes. M: pUC19 DNA/MspI (HpaII) marker 23; lane 1: genotype B (281 bp); lane 2: genotype C (122 bp); lane 3: genotype B+C; lane 4: negative control.

Citation: Chu RH, Ma LX, Wang G, Shao LH. Influence of HLA-DRB1 alleles and HBV genotypes on interferon-α therapy for chronic hepatitis B. World J Gastroenterol 2005; 11(30): 4753-4757
URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4753.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4753